MA1-110

antibody from Invitrogen Antibodies

Targeting: NES FLJ21841

Provider product page for MA1-110

Western blot

Immunocytochemistry

Immunohistochemistry

Flow cytometry

Other assay

Antibody data

Antibody Data
Antigen structure
References [27]
Comments [0]
Validations
Immunocytochemistry [7]
Flow cytometry [3]
Other assay [12]

Submit

Product number: MA1-110 - Provider product page
Provider: Invitrogen Antibodies
Product name: Nestin Monoclonal Antibody (10C2)
Antibody type: Monoclonal
Antigen: Other
Description: MA1-110 has been successfully utilized in Western Blot, immunocytochemistry, flow cytometry, and immunofluorescence applications in human samples. MA1-110 also acts a neuronal stem cell marker and detects a band in Western blot at ~250 kDa.
Reactivity: Human, Mouse
Host: Mouse
Isotype: IgG
Antibody clone number: 10C2
Vial size: 100 µg
Concentration: 1 mg/mL
Storage: -20°C

NES protein structure - MA1-110 shown in red.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescent analysis of nestin (green) in U251 cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes at room temperature and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with a nestin Monclonal Antibody (Product # MA1-110) at a dilution of 1:20 and incubated overnight in a humidified chamber. Cells were washed with PBST and incubated with a DyLight-conjugated secondary antibody for 45 minutes at room temperature in the dark. F-actin (red) was stained with a fluorescent phalloidin and nuclei (blue) were stained with DAPI. Images were taken at a 60X magnification.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescent analysis of nestin (green) in human cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes at room temperature and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with a nestin Monclonal Antibody (Product # MA1-110) at a dilution of 1:20 and incubated overnight in a humidified chamber. Cells were washed with PBST and incubated with a DyLight-conjugated secondary antibody for 45 minutes at room temperature in the dark. F-actin (red) was stained with a fluorescent phalloidin and nuclei (blue) were stained with DAPI. Images were taken at a 60X magnification.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescent analysis of nestin (green) in murine cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes at room temperature and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with a nestin Monclonal Antibody (Product # MA1-110) at a dilution of 1:20 and incubated overnight in a humidified chamber. Cells were washed with PBST and incubated with a DyLight-conjugated secondary antibody for 45 minutes at room temperature in the dark. F-actin (red) was stained with a fluorescent phalloidin and nuclei (blue) were stained with DAPI. Images were taken at a 60X magnification.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescent analysis of Nestin (green) U2-0S cells. Formalin fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature and blocked with 0.3% BSA/TBST (Product # 37525) for 15 minutes at room temperature. Cells were probed with a Nestin monoclonal antibody (Product # MA1-110) at a dilution of 1:200 for at least 1 hour at room temperature, washed with PBS, and incubated with DyLight 488 goat-anti-mouse IgG secondary antibody (Product # 35502) at a dilution of 1:400 for 30 minutes at room temperature. Nuclei (blue) were stained with Hoechst 33342 dye (Product # 62249). Images were taken on a Thermo Scientific ArrayScan at 20X magnification.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescent analysis of Nestin (green) in human neural stem cells derived from PD-3 iPSCs using Gibco® PSC Neural Induction Medium (Product # A1647801). The cells were fixed and permeabilized using Image-IT® Fixation/Permeabilization kit (Product # R37602), and blocked with the including blocking buffer for one hour at room temperature. Cells were stained with a Nestin monoclonal antibody (Product # MA1-110) at a dilution of 1:100 in blocking buffer for 3 hours at room temperature, and then incubated with a DyLight488-conjugated goat anti-mouse IgG secondary antibody (Product # 35502) at a dilution of 1:250 for 1 hour at room temperature. Nucleus DNA (blue) was stained with DAPI (Product # D1306). Images were taken on an EVOS® FLoid® Cell Imaging Station at 10X magnification.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescence analysis of Nestin was performed using 70% confluent log phase NSC differentiated to neurons. The cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 15 minutes, and blocked with 2% BSA for 45 minutes at room temperature. The cells were labeled with Nestin Monoclonal Antibody (10C2) (Product # MA1-110) at 1:250 in 0.1% BSA, incubated at 4 degree celsius overnight and then labeled with Donkey anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 488 (Product # A32766), (1:2500), for 45 minutes at room temperature (Panel a: Green). Nuclei (Panel b:Blue) were stained with ProLong™ Diamond Antifade Mountant with DAPI (Product # P36962). F-actin (Panel c: Red) was stained with Rhodamine Phalloidin (Product # R415, 1:300). Panel d represents the merged image showing Cytosolic localization. Panel e represents NSC with lower expression of Nestin. Panel f represents control cells with no primary antibody to assess background. The images were captured at 60X magnification.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: For immunofluorescence analysis, iPSC differentiated to Neural Rosettes were fixed and permeabilized for detection of endogenous Nestin using Anti-Nestin mouse monoclonal antibody (Product # MA1-110, 1:100 dilution) and labeled with Goat anti-Rabbit IgG (H+L) Superclonal™ Secondary Antibody, Alexa Fluor® 488 conjugate (Product # A27023, 1:2000). Panel b) shows representative cells that were stained for detection and localization of Nestin protein (green) in the cytoplasm of Neural Rosettes in comparison to iPSC (a).

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Flow cytometry analysis of Nestin in SH-SY5Y cells (green) compared to an isotype control (blue). Cells were harvested, adjusted to a concentration of 1-5x10^6 cells/mL, fixed with 2% paraformaldehyde and washed with PBS. Cells were blocked with a 2% solution of BSA-PBS for 30 min at room temperature and incubated with a Nestin monoclonal antibody (Product # MA1-110) at a dilution of 1 µg/test for 40 min at room temperature. Cells were then incubated for 40 min at room temperature in the dark using a Dylight 488-conjugated secondary antibody and re-suspended in PBS for FACS analysis.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Flow cytometry analysis of Nestin in U251 cells (green) compared to an isotype control (blue). Cells were harvested, adjusted to a concentration of 1-5x10^6 cells/mL, fixed with 2% paraformaldehyde and washed with PBS. Cells were blocked with a 2% solution of BSA-PBS for 30 min at room temperature and incubated with a Nestin monoclonal antibody (Product # MA1-110) at a dilution of 1 µg/test for 40 min at room temperature. Cells were then incubated for 40 min at room temperature in the dark using a Dylight 488-conjugated secondary antibody and re-suspended in PBS for FACS analysis.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Flow cytometry analysis of Nestin on human neural stem cells derived from PD-3 iPSCs using Gibco® PSC Neural Induction Medium (Product # A1647801). Cells were fixed, permeabilized, and then stained with 1 µg of Nestin monoclonal antibody (Product # MA1-110, red histogram) or mouse IgG1 isotype control (black histogram) in 5% BSA. After incubation of the primary antibody for 1 hour on ice, the cells were stained with a DyLight 488-conjugated goat anti-mouse IgG secondary antibody (Product # 35502) at a dilution of 1:500 for 1 hour on ice. A representative 10,000 cells were acquired for each sample.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: FIGURE 4 Quantification of early neurons derived from F-mEpiSCs and NT-mEpiSCs. (A) Immunofluorescence staining for Nestin, Pax6, and Tuj1 of early neurons derived from F-mEpiSCs and NT-mEpiSCs; nuclei are shown using DAPI (B) Quantification of Tuj1-positive and Pax6-positive cells based on Tuj1 and Pax6 immunofluorescence staining. (C) Flow cytometry analysis of F-EpiSCs and NT-EpiSCs stained for the neuronal marker NeuroD1. Mouse Neuro-2A cells served as positive control for the staining. Data were acquired for a minimum of 10 x 10 3 events per sample using the FC500 flow cytometer and analyzed using the FlowJo software. Scale bar: 25 mum; n.s., P > 0.05; ** P < 0.01.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 2. Automated midbrain organoids express typical neural and midbrain markers and show signs of structural organization. ( a ) Expression of the dopaminergic midbrain marker TH as well as the precursor markers nestin and Sox2 is evenly distributed throughout the entire aggregate at day 25, as shown by single confocal microscopy slices of tissue-cleared samples. The dotted box indicates the area shown in ( b ). Here, higher magnification of the peripheral aggregate region reveals two different zones with few nuclei but dense, circumferentially oriented neurites distally from the core and radial organization of TH-positive neurons more proximally. ( c ) The expression patterns of DCX and Brn2 further illustrate the organization of neurons (DCX) and neural precursors (Brn2) in the core of AMOs into zones. ( d ) Enlargement (of the dotted box in c) highlighting the circumferential organization of neurons (DCX) surrounding the core. ( e ) Maximum intensity projection (MIP) of fluorescent confocal images showing a dense cellular network expressing the neural marker beta-tubulin III (TUBB33) within the AMOs at d25. ( f/g ) Continuing maturation of AMOs is indicated by the presence of synapses marked by the colocalization of the presynaptic synaptophysin and postsynaptic homer on Map2-positive neurites at day 50 (f, top right corner showing enlargement of two synapses without the Map2 channel) and S100b/GFAP double-positive astrocytes at day 75 ( g ). Scale bars: 100 mum ( a, c,

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: FIGURE 3 The effect of CA genotype on STMN2 mRNA expression in olfactory neurosphere derived cell lines and laser captured spinal motor neurons. (A) Immunostaining of ONS cells with Nestin, NeuN, and beta-tubulin. (B) Variable expression of STMN2 in sALS ONS cell lines (lanes 5-8) compared to control ONS cell lines (lanes 1-4). (C) Relative densitometry of TARDBP and STMN2 standardized to GAPDH expression showing variable expression of STMN2 in sALS cell lines and no difference in TARDBP . (D) Trend for a stepwise decrease in STMN2 mRNA expression between control and sALS cases according to STMN2 CA genotype (S/L vs. L/L), error bars represent standard error of the mean. RNA sequencing data was analyzed by and STMN2 expression between cases and controls previously reported (). (E) Percentage of motor neurons positive for phosphorylated TDP-43 during initial sample collection done by , according to STMN2 CA genotype. (F) Percentage of motor neuron death according to STMN2 CA genotype based on data collected by .

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: FIGURE 3 CPNE7 stimulates odontoblast process elongation. (A) Both stages of hDPCs were treated with rCPNE7, 3-MA, rCPNE7 + 3-MA, or rapamycin for 24 h. NESTIN and total-TAU protein levels were evaluated by western blot analysis. (B,C) The morphology of hDPCs was analyzed in each group 7 days after treatment. Boxed areas are shown at higher magnification. (B) Cells were observed under an optical microscope (100 x). Odontoblasts with a unidirectional odontoblast process-like structure (green arrows) were observed in the rCPNE7 group. Multidirectional odontoblast process-like structures were observed (red arrowheads) in the rapamycin group. (C) Representative immunofluorescence images of TUBULIN (green) and TAU (red) in each group of treated cells. TUBULIN and TAU expression was co-localized in the odontoblast process-like structures in the rCPNE7 group (arrows). Scale bars = 50 mum and 20 mum. Significant differences are shown with asterisks. * P < 0.05.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 2 CD11c+ cell at dentin-pulp interface does not express odontoblast differentiation markers of DMP1 and Nestin. ( a ) Single-plane images of the tooth extracted from CD11c-YFP mouse after immunostaining of DMP1. Yellow arrowhead marks CD11c+ cell at the dentin-pulp interface. Scale bar, 50 mum. DMP1 (red), CD11c (green), DAPI (cyan). ( b ) Single plane images of the tooth extracted from CD11c-YFP mouse after immunostaining of Nestin. Yellow arrowhead marks CD11c+ cell at the dentin-pulp interface. Scale bar, 50 mum. Nestin (red), CD11c (green), DAPI (cyan). White dotted lines delineate the dentin-pulp interface. D : dentin, P : pulp, OB : odontoblast layer.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Fig. 2 EGF promotes astrocyte dedifferentiation. A Immunostaining of cells with GFAP, Nestin and Olig2 antibodies 5 days after transdifferentiation. B Quantification of immune-positive cells in the four cultures. C Western blotting analysis of GFAP, Nestin and Olig2 on d5 during the transdifferentiation process. D - F Quantitative analysis of GFAP, Nestin and Olig2 proteins expression in the four cultures on d5, respectively, histograms express results in arbitrary units, taking Ctrl cells values as 100%. G Quantitative RT-PCR analysis of the expression level of GFAP, Glast, NFIA and Sox9 in the four groups on d5 during the transdifferentiation process and Sox10 + EGF + Gefitinib group cells treated with FBS for another 3 days. Statistical analyses are presented as Mean +- SD, n = 3. **P < 0.01, ***P < 0.001. Scale bars, 50 mum

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Expression of stemness markers: immunocytochemistry images of ( A ) Sox2 primary antibody stained with FITC and counterstained with DAPI; ( B ) Nestin-primary antibody stained with PE and counterstained with DAPI. The scale bar indicates 20 um.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Characterization of hiPSC derived hNPCs, neurons and astrocytes. a Immunostainings exemplarily shown for O3H-R1-003. hiPSC pluripotency staining for markers OCT4, NANOG, SOX2. Scale bar=200 um. hNPC staining for markers SOX1, SOX2, NESTIN, PAX6. Scale bar=100 um. Neuron staining for markers TUBB3 and DAn marker TH. Scale bar=100 um. Astrocyte staining for markers GFAP and SLC1A3. Scale bar=100 um. b Summary of somatic CNVs identified in hNPC clones by chromosomal microarray analysis shown as total number of somatic CNVs detected per analyzed clone and average length of CNVs (in kb; green=copy number gain; orange=copy number loss) per analyzed clone. n = 5 Ctrl and 7 sPD patients. c Circos plot showing the genomic distribution of somatic CNVs in Ctrl (blue) and sPD (red) clones. d Quantification of RBFOX3 (synonym: NeuN) positive as well as TH / RBFOX3 double-positive cells in DAn populations. n = 5 Ctrl and 7 sPD clones, in triplicates. e Characterization of neurite morphologies of DAns. Boxplots show the average number of neurites emerging from TH positive cell bodies, their average number of branch points and their average length. n = 5 Ctrl and 7 sPD clones, in triplicates. Boxplots display the median and range from the 25th to 75th percentile. Whiskers extend from the min to max value. Each dot represents one patient. P -values were determined by two-sided t -test d (right), e ; two-sided Mann-Whitney-U test b, d (left). * p < 0.05, ** p < 0.01, *** p < 0.001. Source data

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 1. Characterization of XCL-1 neural stem cells (NSCs). ( A ) Cytogenetic characterization of NSCs by karyotyping. Image of chromosome from a metaphase spread of XCL1 showing normal number and banding pattern of each of the 22 pairs of autosomes, X and Y chromosomes. ( B ) Proliferation curve of XCL1, with the values represented as mean +- SEM of 3 independent measurements. Y-axis depicts the number of cells and the X-axis, age in hours ( C ) Confocal images of XCL-1 showing the expression of (i-iii) Nestin/SOX1. Confocal images of (iv-vi) Nestin/SOX2 and (vii-ix) Ki-67/DAPI. The NSCs were regularly observed in their typical neural rosette morphology. The confocal images in this panel were brightness adjusted using ImageJ for better visualization. Scale bar 50 mum.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: 3 FIGURE Neural differentiation of patient-derived induced pluripotent stem cells (iPSCs) to neural progenitor cells and neurons. (a) Schematic of neural differentiation from EIEE-76 patient-specific iPSCs. (b) Neural progenitor cells (NPCs) differentiated from control (Unaffected: CW067 U5; CW067 U9) and an EIEE-76 patient (Affected: CW066 A4; CW066 A5) iPSC clones are indistinguishable. The iPSCs clones form embryoid bodies (EBs) and neural rosettes (yellow, dashed outline) similarly upon neural induction. Isolated NPCs express neural progenitor cell markers PAX6 and NESTIN. Representative images shown with DAPI (4',6-diamidino-2-phenylindole) counterstain. Scale bar, 100 mum. (c) Characterization of NPC lines derived from unaffected familial control (CW067) and an EIEE-76 affected patient (CW066) by RT-PCR for expression of neural crest cell ( SOX10 and FOXD3), stem cell ( OCT4), and neural progenitor cell ( NESTIN ) identity genes show the NPC cultures are not contaminated by neural crest derivatives or undifferentiated stem cells. GAPDH , loading control. (d) Co-immunocytochemistry for neuronal markers MAP2 and TUJ1 at day (d)25 of differentiation show positive expression in familial unaffected controls and EIEE-76 patient-specific affected neurons. Representative images shown with DAPI counterstain. Scale bar, 50 mum. (e) Dual color infrared western blot for HA (green) and ACTL6B (red) in HEK293T cell lysates transfected with a 2xHA-epitope tagged ACTL6B expression cons